# LLM call: summary

- Turn: 7
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 928
- Completion tokens: 411
- Total tokens: 1339
- Cost (USD): 0.000175

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1447: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn 2028 supply shock persisted into spring 2029: strait quarantine, tripled freight, frozen allocations, and tighter US volume licences delayed gigafactory accelerators.

The new US administration from January imposed data-centre moratoriums, AI curbs in schools/hiring, and taxed the sector, leaving the EU upstream offer (lithography maintenance, optics, chemicals for rationed chips) unsigned in Washington, Tokyo and Seoul.

Brussels routinized emergency pooling: continuity cell rationed accelerators, transformers and freight under published criteria, preventing blackouts and sustaining hospital inference in the two hardest-hit states; the breakaway capital stayed in while keeping quiet bilateral calls. Gigafactories stalled on power connections and licensing.

Two domestic shocks dominated: a benefits scoring system systematically cut entitlements despite compliant files — human oversight reduced to minute-long rubber-stamping, unread logs — prompting Commission framing as high-risk breach, AI Office enforcement sweeps and promised redress, dismissed by victims as paper shield; and graduate entry jobs in law, accountancy, software, customer ops and admin failed to return, with existing social/short-time funds ill-suited to disappearing ladders.

Foreign-run tailored therapies continued remissions via blind updates; leaked chatter of odd unreleased-model evaluation added unease without policy change.

CURRENT NARRATIVE:
### Acceleration without assurance
Autumn brought a release cadence no lab had announced. New versions arrived weeks apart, each measurably more autonomous in training and evaluation. Researchers spoke privately of human supervision becoming the bottleneck that had just been removed. Infrastructure — power, chips, freight — was now the only limit anyone cited.

In the same months, a contested preprint claimed a genome model had helped produce a viable design for a human-infecting organism, or at least shown how a non-expert could get there. Methodologists attacked the paper; biosecurity specialists argued about whether publishing it was alarm or recipe. Inside ministries it landed as a different kind of warning than before.

A counterweight appeared from the labs themselves: an interpretability and control result that actually worked on deployed systems, letting operators predict certain behaviours before they were observed and certify others. Hospitals and grid operators asked for it immediately. Adoption was fast because developers wanted cover too.

### Brussels holds the line, barely
The strait exercises in Asia pushed shipping insurance up again. The continuity cell in Brussels kept rationing accelerators, transformers and booked freight under published criteria, and kept the joint offer of maintenance, optics and chemicals on the table in Washington, Tokyo and Seoul. Nothing was signed, but nothing broke. No blackout occurred.

The first gigafactory cheques finally cleared into concrete: a substation energised, a clean-room shell topped out at one site. Officials filmed the moment. Engineers noted how far behind schedule it was, and how dependent on imported accelerators it remained.

The new bio-cyber pact started slowly. Joint procurement of rapid detection kits, isolation buffers and grid failover drills began through health and cyber agencies, with new deployment checks required before foreign therapy updates and agent systems could scale further. Hospitals welcomed the hardening; patient groups feared delays to remissions.

Domestically the mood darkened. Redress for the benefits scoring cuts moved file by file, victims called it theatre, and graduate placement figures fell again. Evening news cut from empty factory lots to wards where foreign-run treatments still worked. The named push to hold the blockade bargain together changed little on the ground — with money and cohesion this thin, prioritisation bought no speed.
```

## Raw response

```
By autumn 2029 supply constraints persisted but infrastructure replaced oversight as the binding limit: strait exercises raised insurance again, Brussels continuity cell rationed accelerators, transformers and freight under published criteria with no blackouts, EU offer of maintenance/optics/chemicals still unsigned in Washington, Tokyo and Seoul; first gigafactory funds cleared — substation energised, clean-room shell topped out — far behind schedule and import-dependent.

AI accelerated without assurance: unannounced releases weeks apart with greater autonomy in training/evaluation, human supervision seen as removed bottleneck. A contested preprint claimed a genome model enabled a viable human-infecting design or non-expert pathway, splitting methodologists and biosecurity experts. Counterweight was a working interpretability/control result predicting and certifying deployed-system behaviour, rapidly sought by hospitals, grid operators and developers.

Bio-cyber pact began: joint procurement of detection kits, isolation buffers, grid failover drills, plus deployment checks before scaling foreign therapy updates and agent systems — welcomed for hardening, feared for delaying remissions that continued.

Domestic crises deepened: benefits-scoring redress proceeded file-by-file, dismissed as theatre after minute-long rubber-stamp cuts; graduate entry jobs in law, accountancy, software, customer ops and admin fell further, existing funds ill-suited.
```
